Somatopause — the age-related decline in growth hormone secretion — is one of the primary biological drivers of male aging. After age 30, GH secretion declines at approximately 14% per decade, contributing to the progressive changes in body composition, sleep quality, energy, libido, and cognitive function that men experience as they age. Sermorelin, a GHRH analog, addresses somatopause by stimulating the pituitary to restore more youthful GH secretion patterns.
Why Sermorelin Over Exogenous GH
Exogenous HGH (human growth hormone) bypasses the pituitary entirely, delivering GH directly. While effective, this approach suppresses the pituitary's own GH production and carries higher risks of side effects (acromegaly, insulin resistance, joint pain) due to non-physiological GH levels. Sermorelin works upstream — stimulating the pituitary to produce GH in its natural pulsatile pattern — preserving the physiological feedback mechanisms that prevent excess.
Body Composition Effects
GH stimulates lipolysis (fat breakdown) and protein synthesis simultaneously — the combination that drives body recomposition. Men on Sermorelin protocols typically report reductions in visceral fat, improvements in lean mass, and better muscle recovery within 3-6 months. These effects are most pronounced in men over 40 who have experienced significant somatopause.
Sleep, Libido, and Cognitive Effects
GH is released primarily during slow-wave sleep, and Sermorelin's enhancement of GH pulsatility improves sleep architecture — particularly the deep sleep stages that are most restorative. Improved sleep quality has cascading benefits for testosterone production (which also peaks during sleep), libido, and cognitive function.